Jump to content

Megazol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 15:38, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Megazol
Clinical data
ATC code
  • None
Identifiers
  • 5-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazol-2-amine
CAS Number
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC6H6N6O2S
Molar mass226.21 g·mol−1
3D model (JSmol)
  • Cn1c(cnc1c2nnc(s2)N)[N+](=O)[O-]

Megazol (CL 64855) is a nitroimidazole based drug that cures some protozoan infections.

A study of nitroimidazoles found the drug extremely effective against T. cruzi and T. brucei which cause Chagas disease and African sleeping sickness, respectively. The drug is considerably more effective than standard benznidazole therapy (for Chagas) which is considered the gold standard.[1] This is despite that other nitroimidazoles proved ineffective against these pathogens.

References

  1. ^ Hall BS, Wilkinson SR (January 2012). "Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation". Antimicrobial Agents and Chemotherapy. 56 (1): 115–23. doi:10.1128/AAC.05135-11. PMC 3256028. PMID 22037852.